ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    Methylprednisolone Pulse Therapy in Severe Covid-19 Pneumonia reduces mortality significantly


    Dr Waseem ud din, Dr Sehar Tariq, Dr Zaid Khan, Dr Shahid Hamid, Dr Mehwish Mushtaq, Dr. Naveed Nazir Shah
    JCDR. 2023: 565-574

    Abstract

    COVID-19 disease can manifest as a wide spectrum ranging from asymptomatic patients to severe COVID pneumonia with the latter leading to morbidity and even death. The human physiological response to COVID infection mainly presents as a hyperacute inflammatory reaction which leads to multi organ damage especially of the lungs. Corticosteroids reduce morbidity and mortality in COVID pneumonia by suppressing the inflammatory reaction and minimizing organ damage. High dose corticosteroids delivered early in the form of pulse therapy have shown an enhanced benefit over routine therapeutic doses.

    Description

    » PDF

    Volume & Issue

    Volume 14 Issue 7

    Keywords